InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX)
CUSIP: N44821101
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Shares, nominal value (euro)0.12 per share
- Shares outstanding
- 67,811,197
- Total 13F shares
- 9,876,168
- Share change
- -266,757
- Total reported value
- $284,830,000
- Price per share
- $28.84
- Number of holders
- 28
- Value change
- -$7,152,528
- Number of buys
- 15
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP N44821101?
CUSIP N44821101 identifies IFRX - InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP N44821101:
Top shareholders of IFRX - InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.2%
|
2,876,080
|
$60,254,000 | — | 31 Dec 2017 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
2.8%
|
1,876,413
|
$39,311,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.2%
|
1,485,896
|
$31,129,000 | — | 31 Dec 2017 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.1%
|
1,438,207
|
$30,130,000 | — | 31 Dec 2017 | |
| Redmile Group, LLC |
13F
|
Company |
1.3%
|
857,300
|
$17,960,000 | — | 31 Dec 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.82%
|
556,455
|
$11,658,000 | — | 31 Dec 2017 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
275,000
|
$5,761,000 | — | 31 Dec 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.3%
|
202,306
|
$4,238,000 | — | 31 Dec 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.29%
|
200,000
|
$4,190,000 | — | 31 Dec 2017 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.26%
|
175,000
|
$3,666,000 | — | 31 Dec 2017 | |
| NORGES BANK |
13F
|
Company |
0.13%
|
90,000
|
$1,886,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
50,742
|
$1,063,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
35,000
|
$733,000 | — | 31 Dec 2017 | |
| Laurion Capital Management LP |
13F
|
Company |
0.02%
|
16,176
|
$339,000 | — | 31 Dec 2017 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.01%
|
6,000
|
$126,000 | — | 31 Dec 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,073
|
$22,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
900
|
$19,000 | — | 31 Dec 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
377
|
$8,000 | — | 31 Dec 2017 |
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q1 2018
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.